blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2155659

EP2155659 - SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  20.01.2017
Database last updated on 25.09.2024
Most recent event   Tooltip20.01.2017Application deemed to be withdrawnpublished on 22.02.2017  [2017/08]
Applicant(s)For all designated states
Bayer Intellectual Property GmbH
Alfred-Nobel-Strasse 10
40789 Monheim / DE
[2012/39]
Former [2011/34]For all designated states
Bayer Pharma Aktiengesellschaft
Müllerstrasse 178
13353 Berlin / DE
Former [2010/08]For all designated states
Bayer Schering Pharma Aktiengesellschaft
Müllerstrasse 178
13353 Berlin / DE
Inventor(s)01 / RUDOLPH, Joachim
1483 Balboa Avenue
Burlingame, California 94010 / US
02 / DUMAS, Jaques
35 Suffolk Lane
Carlisle, Massachusetts 01741 / US
03 / LI, Yingfu
48 Tanglewood Drive
Hamden, Connecticut 06518 / US
04 / AUCLAIR, Daniel
150 Pheasant Drive
Middletown, Connecticut 06457 / US
05 / LOBELL, Mario
Am Eigenbach 16
42113 Wuppertal / DE
06 / HITCHCOCK, Marion
Pfeddersheiiner Weg 51a
14129 Berlin / DE
07 / HARTUNG, Ingo
Schmiedestrasse 12
40699 Erkrath / DE
08 / KOPPITZ, Marcus
Scharnhorststr. 28
10115 Berlin / DE
09 / BRITTAIN, Dominic
Sredzkistr. 57
10405 Berlin / DE
10 / PUEHLER, Florian
Jules-Verne-Strasse 50
14089 Berlin / DE
11 / PETERSEN, Kirstin
Kufsteiner Strasse 10
10825 Berlin / DE
12 / GUENTHER, Judith
Parkstrasse 60
13187 Berlin / DE
13 / BADER, Benjamin
Hillmannstrasse 14
13467 Berlin / DE
 [2010/08]
Representative(s)BIP Patents
c/o Bayer Intellectual Property GmbH
Alfred-Nobel-Straße 50
40789 Monheim am Rhein / DE
[N/P]
Former [N/P]BIP Patents
c/o Bayer Intellectual Property GmbH
Creative Campus Monheim
Alfred-Nobel-Straße 10
DE-40789 Monheim / DE
Former [2013/01]BIP Patents
Creative Campus Monheim
Alfred-Nobel-Straße 10
40789 Monheim / DE
Former [2012/39]Bayer Intellectual Property GmbH
Creative Campus Monheim
Alfred-Nobel-Straße 10
40789 Monheim / DE
Application number, filing date08749469.609.05.2008
[2010/08]
WO2008EP03936
Priority number, dateUS20070928789P11.05.2007         Original published format: US 928789 P
EP2008007531422.04.2008         Original published format: EP 08075314
[2010/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008138639
Date:20.11.2008
Language:EN
[2008/47]
Type: A1 Application with search report 
No.:EP2155659
Date:24.02.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 20.11.2008 takes the place of the publication of the European patent application.
[2010/08]
Search report(s)International search report - published on:EP20.11.2008
ClassificationIPC:C07C217/92, C07C233/65, C07C255/59, C07C271/16, C07C307/10, C07D211/22, C07D317/22, C07D497/04, C07D295/088, A61K31/136, A61K31/4465, A61K31/277, A61K31/167, A61K31/357, A61K31/495
[2010/08]
CPC:
C07D233/60 (EP,US); A61P11/06 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P25/28 (EP); A61P27/02 (EP);
A61P27/06 (EP); A61P27/12 (EP); A61P29/00 (EP);
A61P3/10 (EP); A61P31/04 (EP); A61P35/00 (EP);
A61P35/02 (EP); A61P35/04 (EP); A61P37/06 (EP);
A61P43/00 (EP); A61P9/04 (EP); A61P9/08 (EP);
A61P9/10 (EP); C07C217/92 (EP,US); C07C237/30 (EP,US);
C07C237/44 (EP,US); C07C243/38 (EP,US); C07C255/58 (EP,US);
C07C255/59 (EP,US); C07C271/16 (EP,US); C07C271/28 (EP,US);
C07C271/44 (EP,US); C07C275/28 (EP,US); C07C275/36 (EP,US);
C07C307/02 (EP,US); C07C307/10 (EP,US); C07C309/66 (EP,US);
C07C311/08 (EP,US); C07C311/09 (EP,US); C07C311/17 (EP,US);
C07C311/48 (EP,US); C07D205/04 (EP,US); C07D207/08 (EP,US);
C07D207/27 (EP,US); C07D207/48 (EP,US); C07D209/08 (EP,US);
C07D211/22 (EP,US); C07D211/46 (EP,US); C07D211/96 (EP,US);
C07D213/30 (EP,US); C07D213/34 (EP,US); C07D213/68 (EP,US);
C07D231/18 (EP,US); C07D233/84 (EP,US); C07D265/30 (EP,US);
C07D277/22 (EP,US); C07D295/088 (EP,US); C07D295/185 (EP,US);
C07D295/26 (EP,US); C07D317/22 (EP,US); C07D317/64 (EP,US);
C07D327/04 (EP,US); C07D403/12 (EP,US); C07C2601/08 (EP,US);
C07C2601/10 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/08]
TitleGerman:SUBSTITUIERTE PHENYLAMINBENZEN-DERIVATE ZUR BEHANDLUNG HYPERPROLIFERATIVER UND DURCH EXTRAZELLULÄRE MITROGENKINASE-AKTIVITÄT HERVORGERUFENER ERKRANKUNGEN[2010/08]
English:SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY[2010/08]
French:DERIVES DE PHENYLAMINO-BENZENE SUBSTITUES UTILES POUR LE TRAITEMENT DE MALADIES ET DE TROUBLES HYPERPROLIFERATIFS ASSOCIES AVEC L'ACTIVITE DES KINASES EXTRACELLULAIRES ACTIVEES PAR DES MITOGENES[2010/08]
Entry into regional phase11.12.2009National basic fee paid 
11.12.2009Designation fee(s) paid 
11.12.2009Examination fee paid 
Examination procedure11.12.2009Examination requested  [2010/08]
20.08.2010Despatch of a communication from the examining division (Time limit: M06)
25.02.2011Reply to a communication from the examining division
15.11.2013Despatch of a communication from the examining division (Time limit: M06)
26.05.2014Reply to a communication from the examining division
19.04.2016Communication of intention to grant the patent
30.08.2016Application deemed to be withdrawn, date of legal effect  [2017/08]
06.10.2016Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2017/08]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.08.2010
Fees paidRenewal fee
31.05.2010Renewal fee patent year 03
24.05.2011Renewal fee patent year 04
27.04.2012Renewal fee patent year 05
10.05.2013Renewal fee patent year 06
16.05.2014Renewal fee patent year 07
12.05.2015Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.05.201609   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]US3867437  (FUJIMURA HAJIME, et al) [X] 1-13,15,24 * 4th,13th,14th,16th,20th,33rd-35th compounds in table 2; column 2, lines 55-60; column 9, line 43 - column 10, line 45;;; examples 3,5,9,21,34; claim 1 *;
 [X]EP0360566  (PFIZER [US]) [X] 1-10 * page 14, lines 35-45 *;
 [A]WO2007014011  (VALEANT RES & DEV [US], et al) [A] 1-25* claims 1,52,53 *;
 [X]  - IAN HUTCHINSON AND MALCOLM F. G. STEVENS, "Synthetic strategies to a telomere-targeted pentacyclic heteroaromatic salt", ORGANIC & BIOMOLECULAR CHEMISTRY, (20061123), vol. 5, pages 114 - 120, XP002491234 [X] 1-10 * Compound 15 on pages 117 and 119 *

DOI:   http://dx.doi.org/10.1039/b613580n
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.